Baraona E, Abittan C S, Dohmen K, Moretti M, Pozzato G, Chayes Z W, Schaefer C, Lieber C S
Section of Liver Disease, Alcohol Research Center, Bronx Veterans Affairs and Mount Sinai Medical Centers, New York 10468, USA.
Alcohol Clin Exp Res. 2001 Apr;25(4):502-7.
The enhanced vulnerability of women to develop alcohol-related diseases may be due to their higher blood alcohol levels after drinking, but the mechanism for this effect is debated.
Sixty-five healthy volunteers of both genders drank 0.3 g of ethanol/kg of body weight (as 5%, 10%, or 40% solutions) postprandially. Blood alcohol concentrations were monitored by breath analysis and compared with those after intravenous infusion of the same dose. First-pass metabolism was quantified (using Michaelis-Menten kinetics) as the route-dependent difference in the amount of ethanol reaching the systemic blood. Gastric emptying was assessed by nuclear scanning after intake of 300 microCurie of technetium-labeled diethylene triamine pentacetic acid in 10% ethanol. The activities of alcohol dehydrogenase isozymes were assessed in 58 gastric biopsies, using preferred substrates for gamma-ADH (acetaldehyde) and for final sigma-ADH (m-nitrobenzaldehyde) and a specific reaction of chi-ADH (glutathione-dependent formaldehyde dehydrogenase).
Women had less first-pass metabolism than men when given 10% or 40%, but not 5%, alcohol. This was associated with lower gastric chi-ADH activity; its low affinity for ethanol could explain the greater gender difference in first-pass metabolism with high rather than with low concentrations of imbibed alcohol. Alcohol gastric emptying was 42% slower and hepatic oxidation was 10% higher in women. A 7.3% smaller volume of alcohol distribution contributed to the higher ethanol levels in women, but it did not account for the route-dependent effects.
The gender difference in alcohol levels is due mainly to a smaller gastric metabolism in females (because of a significantly lesser activity of chi-ADH), rather than to differences in gastric emptying or in hepatic oxidation of ethanol. The concentration-dependency of these effects may explain earlier discrepancies. The combined pharmacokinetic differences may increase the vulnerability of women to the effects of ethanol.
女性更易患酒精相关疾病,这可能是由于她们饮酒后血液酒精水平较高,但其作用机制仍存在争议。
65名健康的男女志愿者餐后饮用0.3g乙醇/千克体重(分别为5%、10%或40%的溶液)。通过呼吸分析监测血液酒精浓度,并与静脉输注相同剂量后的浓度进行比较。首过代谢(采用米氏动力学)被量化为到达体循环血液的乙醇量的途径依赖性差异。摄入300微居里的锝标记二乙烯三胺五乙酸于10%乙醇中后,通过核扫描评估胃排空情况。在58份胃活检样本中,使用γ-ADH(乙醛)和最终的σ-ADH(间硝基苯甲醛)的首选底物以及χ-ADH(谷胱甘肽依赖性甲醛脱氢酶)的特异性反应来评估酒精脱氢酶同工酶的活性。
给予10%或40%而非5%的酒精时,女性的首过代谢比男性少。这与胃χ-ADH活性较低有关;其对乙醇的低亲和力可以解释在摄入高浓度而非低浓度酒精时首过代谢中更大的性别差异。女性的酒精胃排空慢42%,肝脏氧化高10%。较小的酒精分布体积(小7.3%)导致女性体内乙醇水平较高,但这并不能解释途径依赖性效应。
酒精水平的性别差异主要是由于女性胃代谢较小(因为χ-ADH活性明显较低),而非胃排空或乙醇肝脏氧化的差异。这些效应的浓度依赖性可能解释了早期的差异。综合的药代动力学差异可能会增加女性对乙醇作用的易感性。